BioSyent Inc. (RX.V)
CAD 10.36
(3.6%)
CAD 10.36
(3.6%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.54 CAD | 22.73% |
| 2022 | 0.44 CAD | -12.0% |
| 2021 | 0.50 CAD | 72.41% |
| 2020 | 0.29 CAD | -6.45% |
| 2019 | 0.31 CAD | -20.51% |
| 2018 | 0.39 CAD | 8.33% |
| 2017 | 0.36 CAD | 20.0% |
| 2016 | 0.30 CAD | 11.11% |
| 2015 | 0.27 CAD | 17.39% |
| 2014 | 0.23 CAD | 64.29% |
| 2013 | 0.14 CAD | 16.67% |
| 2012 | 0.12 CAD | 300.0% |
| 2011 | 0.03 CAD | 650.0% |
| 2010 | 0.00 CAD | 119.14% |
| 2009 | -0.02 CAD | 9.52% |
| 2008 | -0.02 CAD | -126.47% |
| 2007 | -0.01 CAD | -134.0% |
| 2006 | 0.03 CAD | -25.0% |
| 2005 | 0.04 CAD | 300.0% |
| 2004 | -0.02 CAD | 44.13% |
| 2003 | -0.04 CAD | 11.6% |
| 2002 | -0.04 CAD | -145.0% |
| 2001 | 0.09 CAD | 320.05% |
| 2000 | -0.04 CAD | 31.83% |
| 1999 | -0.06 CAD | 62.5% |
| 1998 | -0.16 CAD | -77.78% |
| 1997 | -0.09 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.14 CAD | -6.67% |
| 2024 Q1 | 0.15 CAD | 25.0% |
| 2023 Q4 | 0.12 CAD | -40.0% |
| 2023 Q1 | 0.10 CAD | -2.02% |
| 2023 Q3 | 0.20 CAD | 66.67% |
| 2023 FY | - CAD | 22.73% |
| 2023 Q2 | 0.12 CAD | 23.46% |
| 2022 Q2 | 0.10 CAD | -24.38% |
| 2022 Q1 | 0.13 CAD | -13.33% |
| 2022 Q3 | 0.12 CAD | 22.08% |
| 2022 Q4 | 0.10 CAD | -17.33% |
| 2022 FY | - CAD | -12.0% |
| 2021 Q2 | 0.08 CAD | -38.46% |
| 2021 Q3 | 0.14 CAD | 75.0% |
| 2021 Q4 | 0.15 CAD | 7.14% |
| 2021 Q1 | 0.13 CAD | 150.0% |
| 2021 FY | - CAD | 72.41% |
| 2020 FY | - CAD | -6.45% |
| 2020 Q3 | 0.08 CAD | 33.93% |
| 2020 Q1 | 0.11 CAD | 26.44% |
| 2020 Q4 | 0.05 CAD | -30.67% |
| 2020 Q2 | 0.06 CAD | -49.09% |
| 2019 Q2 | 0.05 CAD | -30.0% |
| 2019 FY | - CAD | -20.51% |
| 2019 Q3 | 0.11 CAD | 124.49% |
| 2019 Q4 | 0.09 CAD | -20.91% |
| 2019 Q1 | 0.07 CAD | -41.67% |
| 2018 Q4 | 0.12 CAD | 33.33% |
| 2018 Q2 | 0.11 CAD | 37.5% |
| 2018 FY | - CAD | 8.33% |
| 2018 Q1 | 0.08 CAD | -20.0% |
| 2018 Q3 | 0.09 CAD | -18.18% |
| 2017 Q3 | 0.09 CAD | -18.18% |
| 2017 FY | - CAD | 20.0% |
| 2017 Q4 | 0.10 CAD | 11.11% |
| 2017 Q2 | 0.11 CAD | 83.33% |
| 2017 Q1 | 0.06 CAD | -21.05% |
| 2016 Q2 | 0.07 CAD | 0.0% |
| 2016 Q4 | 0.08 CAD | -15.56% |
| 2016 Q1 | 0.07 CAD | 29.63% |
| 2016 Q3 | 0.09 CAD | 28.57% |
| 2016 FY | - CAD | 11.11% |
| 2015 Q1 | 0.07 CAD | 29.63% |
| 2015 Q2 | 0.06 CAD | -14.29% |
| 2015 FY | - CAD | 17.39% |
| 2015 Q4 | 0.05 CAD | -40.0% |
| 2015 Q3 | 0.09 CAD | 50.0% |
| 2014 Q4 | 0.05 CAD | -22.86% |
| 2014 Q3 | 0.07 CAD | 16.67% |
| 2014 Q2 | 0.06 CAD | 50.0% |
| 2014 Q1 | 0.04 CAD | -2.44% |
| 2014 FY | - CAD | 64.29% |
| 2013 Q1 | 0.03 CAD | -21.05% |
| 2013 Q2 | 0.03 CAD | 0.0% |
| 2013 Q3 | 0.04 CAD | 33.33% |
| 2013 Q4 | 0.04 CAD | 2.5% |
| 2013 FY | - CAD | 16.67% |
| 2012 Q4 | 0.04 CAD | 26.67% |
| 2012 Q3 | 0.03 CAD | 0.0% |
| 2012 Q2 | 0.03 CAD | 50.0% |
| 2012 Q1 | 0.02 CAD | 284.62% |
| 2012 FY | - CAD | 300.0% |
| 2011 Q1 | -0.00 CAD | -101.49% |
| 2011 FY | - CAD | 650.0% |
| 2011 Q4 | 0.01 CAD | -74.0% |
| 2011 Q3 | 0.02 CAD | 100.0% |
| 2011 Q2 | 0.01 CAD | 10100.0% |
| 2010 Q1 | -0.00 CAD | 69.85% |
| 2010 Q4 | 0.01 CAD | -33.0% |
| 2010 Q3 | 0.01 CAD | 214.94% |
| 2010 Q2 | -0.01 CAD | -112.2% |
| 2010 FY | - CAD | 119.14% |
| 2009 Q1 | -0.01 CAD | 0.74% |
| 2009 Q4 | -0.01 CAD | -223.64% |
| 2009 Q2 | -0.01 CAD | 62.96% |
| 2009 Q3 | 0.01 CAD | 320.0% |
| 2009 FY | - CAD | 9.52% |
| 2008 FY | - CAD | -126.47% |
| 2008 Q4 | -0.01 CAD | -440.0% |
| 2008 Q3 | 0.00 CAD | 150.0% |
| 2008 Q2 | -0.01 CAD | -35.59% |
| 2008 Q1 | -0.01 CAD | 53.54% |
| 2007 Q2 | -0.01 CAD | -400.0% |
| 2007 FY | - CAD | -134.0% |
| 2007 Q1 | -0.00 CAD | -134.29% |
| 2007 Q4 | -0.01 CAD | -174.71% |
| 2007 Q3 | 0.02 CAD | 241.67% |
| 2006 Q1 | 0.00 CAD | 146.15% |
| 2006 FY | - CAD | -25.0% |
| 2006 Q4 | 0.01 CAD | -72.0% |
| 2006 Q3 | 0.02 CAD | 757.89% |
| 2006 Q2 | -0.00 CAD | -226.67% |
| 2005 Q4 | -0.01 CAD | -230.0% |
| 2005 Q3 | 0.01 CAD | 655.56% |
| 2005 FY | - CAD | 300.0% |
| 2005 Q1 | 0.04 CAD | 469.75% |
| 2005 Q2 | -0.00 CAD | -102.05% |
| 2004 Q4 | -0.01 CAD | -376.0% |
| 2004 Q1 | -0.01 CAD | 66.26% |
| 2004 Q2 | -0.01 CAD | -1.82% |
| 2004 FY | - CAD | 44.13% |
| 2004 Q3 | -0.00 CAD | 55.36% |
| 2003 Q1 | -0.02 CAD | -29.29% |
| 2003 FY | - CAD | 11.6% |
| 2003 Q4 | -0.02 CAD | -443.33% |
| 2003 Q3 | -0.00 CAD | 54.55% |
| 2003 Q2 | -0.01 CAD | 63.54% |
| 2002 Q1 | -0.02 CAD | -116.17% |
| 2002 Q2 | -0.01 CAD | 30.93% |
| 2002 Q4 | -0.01 CAD | -75.0% |
| 2002 FY | - CAD | -145.0% |
| 2002 Q3 | -0.01 CAD | 40.3% |
| 2001 Q3 | 0.00 CAD | 103.38% |
| 2001 Q1 | -0.02 CAD | -46.73% |
| 2001 FY | - CAD | 320.05% |
| 2001 Q4 | 0.12 CAD | 23900.0% |
| 2001 Q2 | -0.01 CAD | 5.73% |
| 2000 Q4 | -0.01 CAD | -991.67% |
| 2000 Q3 | 0.00 CAD | 112.0% |
| 2000 Q2 | -0.01 CAD | 50.0% |
| 2000 Q1 | -0.02 CAD | 33.33% |
| 2000 FY | - CAD | 31.83% |
| 1999 Q3 | 0.01 CAD | 200.0% |
| 1999 Q4 | -0.03 CAD | -400.0% |
| 1999 Q1 | -0.02 CAD | 0.0% |
| 1999 FY | - CAD | 62.5% |
| 1999 Q2 | -0.01 CAD | 50.0% |
| 1998 Q1 | -0.01 CAD | 0.0% |
| 1998 Q4 | -0.02 CAD | 0.0% |
| 1998 FY | - CAD | -77.78% |
| 1998 Q3 | -0.02 CAD | 77.78% |
| 1998 Q2 | -0.09 CAD | -800.0% |
| 1997 Q4 | -0.01 CAD | 66.67% |
| 1997 Q3 | -0.03 CAD | 0.0% |
| 1997 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -0.02 CAD | 2510.714% |
| CanadaBis Capital Inc. | 0.03 CAD | -1566.667% |
| Decibel Cannabis Company Inc. | -0.00 CAD | 12658.14% |
| Delivra Health Brands Inc. | 0.00 CAD | -17319.355% |
| Entourage Health Corp. | -0.15 CAD | 460.0% |
| Lifeist Wellness Inc. | -0.58 CAD | 193.103% |
| Cannara Biotech Inc. | 0.08 CAD | -594.087% |
| Medicure Inc. | -0.09 CAD | 711.552% |
| PharmaCielo Ltd. | -0.10 CAD | 640.0% |
| Rubicon Organics Inc. | -0.03 CAD | 1771.827% |
| Voyageur Pharmaceuticals Ltd. | -0.01 CAD | 5146.729% |